Intrepid Potash (NYSE:IPI) reported quarterly earnings of $2.31 per share which beat the analyst consensus estimate of $1.95 by 18.46 percent. This is a 1183.33 percent increase over earnings of $0.18 per share from the same period last year.
HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Buy rating and announces Price Target of $10.